Literature DB >> 3838363

Cancer risks in patients with chronic lymphocytic thyroiditis.

L E Holm, H Blomgren, T Löwhagen.   

Abstract

The incidence of malignant tumors and leukemia was analyzed in 829 patients with chronic lymphocytic thyroiditis and in 829 individually age-matched and sex-matched patients with colloid goiter. Diagnoses were based on cytologic studies of specimens obtained by fine-needle aspiration biopsy. The patients were examined between 1959 and 1978 and were followed in the Swedish Cancer Register between 1959 and 1981. There was no increased risk for the total number of tumors in the thyroiditis group (53 observed vs. 52.7 expected) or in the colloid-goiter group (40 vs. 53.2, respectively; P not significant). There were six lung cancers in the thyroiditis group (2.9 expected, P not significant), and one in the group with colloid goiter. Patients with thyroiditis had an increased risk of myeloproliferative and lymphoproliferative neoplasms (12 observed vs. 3.0 expected, P less than 0.001). The risk of malignant thyroid lymphoma was greatly increased, with an estimated relative risk of 67 (4 observed vs. 0.06 expected, P less than 0.000001). There was no increased risk for any type of tumor among patients with colloid goiter.

Entities:  

Mesh:

Year:  1985        PMID: 3838363     DOI: 10.1056/NEJM198503073121001

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  96 in total

1.  Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis.

Authors:  Jennifer L Hunt; Zubair W Baloch; Leon Barnes; Patricia A Swalsky; Cindy L Trusky; E Sesatomi; Sydney Finkelstein; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 2.  Management of thyroid nodules: a clinicopathological, evidence-based approach.

Authors:  Furio Pacini; Luca Burroni; Cristina Ciuoli; Giovanni Di Cairano; Elisa Guarino
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-08       Impact factor: 9.236

3.  INTEGRATING CLINICAL LABORATORY MEASURES AND ICD-9 CODE DIAGNOSES IN PHENOME-WIDE ASSOCIATION STUDIES.

Authors:  Anurag Verma; Joseph B Leader; Shefali S Verma; Alex Frase; John Wallace; Scott Dudek; Daniel R Lavage; Cristopher V Van Hout; Frederick E Dewey; John Penn; Alex Lopez; John D Overton; David J Carey; David H Ledbetter; H Lester Kirchner; Marylyn D Ritchie; Sarah A Pendergrass
Journal:  Pac Symp Biocomput       Date:  2016

4.  Pleural non-Hodgkin's lymphoma arising in a patient with a chronic pyothorax.

Authors:  N Y Hsu; C Y Chen; S T Pan; C P Hsu
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

5.  Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.

Authors:  G Papi; S M Corsello; K Cioni; A M Pizzini; S Corrado; C Carapezzi; G Fadda; A Baldini; C Carani; A Pontecorvi; E Roti
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 6.  Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model.

Authors:  H Rubén Harach; Gustavo A Ceballos
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

7.  Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis.

Authors:  S Schröder; V Bay; K Dumke; B Kremens; H W Müller-Gärtner; W Böcker; H Kastendieck
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 8.  Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.

Authors:  Richard J Bende; Febe van Maldegem; Carel J M van Noesel
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

9.  Thyroidal prelymphoma.

Authors:  S Matsubayashi; H Tamai; Y Takaichi; T Morita; F Matsuzuka; T Suzuki; K Kuma; S Nagataki
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

10.  Thyroid cancer: current molecular perspectives.

Authors:  Francesca Giusti; Alberto Falchetti; Francesco Franceschelli; Francesca Marini; Annalisa Tanini; Maria Luisa Brandi
Journal:  J Oncol       Date:  2010-03-29       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.